Applied Clinical Trials-04-01-2015

April 01, 2015

Media rebuke of Europe’s Innovative Medicines Initiative thrusts debate into the public arena.

April 01, 2015

Study shows that industry contributions to R&D go well beyond the applied area of clinical testing.

April 01, 2015

Successful conduct of hematological malignancy trials requires addressing several unique complexities.

April 01, 2015

How the practical application of these methods can help overcome the complex demands of cancer trials.

April 01, 2015

Evaluating the use of new tumor measurement tools for studies of molecular-targeted cancer therapies.

April 01, 2015

The need for robust and standardized psychiatric outcomes measures in oncology trials has grown immensely

April 01, 2015

Building a structure for managing study operations through linking trial- and site-level forecasting.

April 01, 2015

Faster go/no-go decisions is the primary driver of adaptive-design adoption by sponsors.

April 01, 2015

The productivity of the U.S. biomedical research enterprise is undergoing a broad re-examination.

April 01, 2015

Initiative designed to boost understanding of medical device development in Europe.

April 01, 2015

Patient focused drug development is playing a larger role in study design and outcome measurement.

April 01, 2015

New ASCO study evaluating the cancer care system reveals mixed findings.

April 01, 2015

Outlining the requirements and benefits of FDA's four expedited drug approval pathways.

April 01, 2015

Following four key study-design steps is crucial to the delivery of a successful cross-border cancer study

April 01, 2015

Trial Design: Breaking Blood Cancer Barriers Adaptive Solutions in Oncology Clinical Technology: Tumor Imaging Ascension Sites: Enrollment Forecast Data Also in this issue: Innovation Initiative Debate in Europe R&D Investment: Public vs. Private The Psychology of Cancer